Shots:
- RetinAI signs a multi-year collaboration with Novartis under which RetinAI’s IT solutions and AI tools will be employed to support multiple projects in ophthalmology and digital health
- The first project under the agreement will support a multi-center international clinical study involving patients with nAMD. The study is designed to investigate the influence of OCT image solutions using AI on the assessment of disease activity
- The study will be conducted across multiple centers in numerous EU countries and Canada, involving 500+ patients. RetinaAI will provide its data management platform to efficiently process data at scale across imaging platforms and devices
Click here to read full press release/ article | Ref: RetinAI | Image: Switzerland Global Enterprise
The post RetinAI Collaborates with Novartis to Provide AI Solutions in Ophthalmology first appeared on PharmaShots.
